CD4 and neoplasm: In conclusion, anti-PD-L1 therapy induces tumor vascular normalization, decreases the proportions of intratumoral PD-L1+ lymphoid and myeloid cells, and inhibits colorectal tumor growth in a CD8+ T cell dependent manner, while CD4+ T cells antagonize those effects.